The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CCIV, ANVS and ATIP
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CCIV, ANVS and ATIP
NEW YORK, NY / ACCESSWIRE / August 29, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
紐約，NY/ACCESSWIRE/2021年8月29日/克萊恩律師事務所宣佈，已代表下列公司的股東提起集體訴訟。參加訴訟是免費的。如果你遭受了損失，你必須在主原告截止日期之前請求法院指定你為主原告。
Churchill Capital Corp IV (NYSE:CCIV)
Class Period: January 11, 2021 - February 22, 2021
Lead Plaintiff Deadline: August 30, 2021
丘吉爾資本公司(Churchill Capital Corp IV)(紐約證券交易所代碼：CCIV) 上課時間：2021年1月11日-2021年2月22日首席原告截止日期：2021年8月30日
The complaint alleges that throughout the class period Churchill Capital Corp IV made materially false and/or misleading statements and/or failed to disclose that: (1) Lucid was not prepared to deliver vehicles by spring of 2021; (2) Lucid was projecting a production of 557 vehicles in 2021 instead of the 6,000 vehicles touted in the run-up to the merger with Churchill; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
起訴書稱，在整個班級期間，Churchill Capital Corp IV做出了重大虛假和/或誤導性陳述和/或未能披露：(1)Lucid沒有準備在2021年春季之前交付車輛；(2)Lucid預計2021年的產量為557輛，而不是在與Churchill合併前吹捧的6000輛；以及(3)由於上述原因，被告對公司業務、運營和前景的積極陳述存在重大誤導當真實細節進入市場時，訴訟稱投資者遭受了損害。
Learn about your recoverable losses in CCIV : http://www.kleinstocklaw.com/pslra-1/churchill-capital-corp-iv-loss-submission-form?id=19082&from=1
瞭解您在CCIV中的可追回損失：http://www.kleinstocklaw.com/pslra-1/churchill-capital-corp-iv-loss-submission-form?id=19082&from=1
Annovis Bio, Inc. (NYSE American:ANVS)
Class Period: May 21, 2021 - July 28, 2021
Lead Plaintiff Deadline: October 18, 2021
Annovis Bio，Inc.(紐約證券交易所美國股票代碼：anVS) 上課時間：2021年5月21日-2021年7月28日首席原告截止日期：2021年10月18日
The ANVS lawsuit alleges that Annovis Bio, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Annovis's ANVS401 (Posiphen), an orally administrated drug which purportedly inhibited the synthesis of neurotoxic proteins that are the main cause of neurodegeneration, did not show statistically significant results across two patient populations as to factors such as orientation, judgement, and problem solving; and (2) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
AnVS訴訟聲稱，Annovis Bio，Inc.作出了重大虛假和/或誤導性陳述和/或未能披露：(1)Annovis的ANVS401(Posiphen)是一種口服藥物，據稱可以抑制神經毒性蛋白的合成，而神經毒性蛋白質是神經變性的主要原因，在兩個患者羣體中，關於定向、判斷和解決問題等因素，Annovis Bio，Inc.沒有顯示出統計上的顯著結果；以及(2)由於上述情況，被告關於以下因素的積極陳述：(1)Annovis‘s ANVS401(Posiphen)是一種口服藥物，據稱可以抑制神經毒性蛋白的合成，而神經毒性蛋白是神經變性的主要原因；(2)由於上述原因，被告對以下因素的積極陳述
Learn about your recoverable losses in ANVS : https://www.kleinstocklaw.com/pslra-1/annovis-bio-inc-loss-submission-form?id=19082&from=1
瞭解您在anVS中的可追回損失：https://www.kleinstocklaw.com/pslra-1/annovis-bio-inc-loss-submission-form?id=19082&from=1
ATI Physical Therapy, Inc. f/k/a Fortress Value Acquisition Corp. II (NYSE:ATIP)
This lawsuit is on behalf of investors who: (a) purchased or otherwise acquired ATI securities between April 1, 2021 and July 23, 2021, inclusive and/or (b) held FVAC Class A common stock as of May 24, 2021 and were eligible to vote at FVAC's June 15, 2021 special meeting.
Lead Plaintiff Deadline: October 15, 2021
ATI物理治療公司f/k/a堡壘價值收購公司II(紐約證券交易所代碼：ATIP) 這起訴訟代表以下投資者：(A)在2021年4月1日至2021年7月23日期間購買或以其他方式獲得ATI證券，和/或(B)截至2021年5月24日持有FVAC A類普通股，並有資格在FVAC 2021年6月15日的特別會議上投票。首席原告截止日期：2021年10月15日
The complaint alleges that throughout the class period ATI Physical Therapy, Inc. f/k/a Fortress Value Acquisition Corp. II made materially false and/or misleading statements and/or failed to disclose that: (1) ATI was experiencing attrition among its physical therapists; (2) ATI faced increasing competition for clinicians in the labor market; (3) as a result of the foregoing, the Company faced difficulties retaining therapists and incurred increased labor costs; (4) as a result of the labor shortage, the Company would open fewer new clinics; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
起訴書聲稱，在整個課程期間，ATI Physical Treatment，Inc.f/k/a堡壘價值收購公司II做出了重大虛假和/或誤導性的陳述和/或未能披露：(1)ATI的物理治療師正在經歷自然減員；(2)ATI在勞動力市場上面臨着對臨牀醫生的日益激烈的競爭；(3)由於上述原因，該公司在留住治療師方面遇到了困難，並導致勞動力成本增加；(4)由於勞動力短缺，公司開設的新診所將減少；(五)因上述原因，被告對公司業務、經營和前景的正面陳述具有重大誤導性和/或缺乏合理依據。
Learn about your recoverable losses in ATIP : https://www.kleinstocklaw.com/pslra-1/ati-physical-therapy-inc-f-k-a-fortress-value-acquisition-corp-ii-loss-submission-form?id=19082&from=1
瞭解您在ATIP中的可追回損失：https://www.kleinstocklaw.com/pslra-1/ati-physical-therapy-inc-f-k-a-fortress-value-acquisition-corp-ii-loss-submission-form?id=19082&from=1
Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
你分享任何賠償的能力並不需要你擔任主要原告。如果您在課程期間遭受損失，並希望獲得更多信息，請聯繫J.Klein，Esq。請致電212-616-4899或訪問提供的網頁。
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
J·克萊因(J.Klein)，Esq.在全國範圍內代表投資者並參與涉及金融欺詐的證券訴訟。律師廣告。先前的結果不能保證類似的結果。
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
聯繫方式：J·克萊因(J.Klein)，Esq.帝國大廈第五大道350號59樓紐約州紐約市，郵編：10118郵箱：jk@kleinstocklaw.com電話：(212)616-4899傳真：(347)558-9665Www.kleinstocklaw.com
SOURCE: The Klein Law Firm
資料來源：克萊恩律師事務所
譯文內容由第三人軟體翻譯。